Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. (Q37330660)
Jump to navigation
Jump to search
scientific article published on December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. |
scientific article published on December 2013 |
Statements
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study (English)
Beatriz Caballero
Richard Civil
Ralf W Dittmann
Esther Cardo
Ralph Bloomfield
Nicholas Higgins
Paul Hodgkins
1 December 2013
20 August 2013
1 reference
1 reference
1 reference